Concepedia

Phuong Vu

PV

Statistics

Publications

13

Citations

1.6K

H-Index

13

Active since

2004

Affiliations

Massachusetts General Hospital(Current)

Norwegian Cancer Society

Oslo University Hospital

University of Oslo

Harvard University

Phuong Vu is an author at Massachusetts General Hospital specializing in medicine, molecular oncology, and oncology.

ORCID

Publications per year

2004–2023

13

Publications

13

Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma

Lipika Goyal, Supriya K. Saha, Leah Y. Liu et al. · Cancer Discovery · 2016 · 545 citations · Full text

, , +17

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Lipika Goyal, Lei Shi, Leah Y. Liu et al. · Cancer Discovery · 2019 · 371 citations · Full text

, , +17

Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma

Supriya K. Saha, John D. Gordan, Benjamin P. Kleinstiver et al. · Cancer Discovery · 2016 · 163 citations

, , +17

TP53 Mutation Spectrum in Smokers and Never Smoking Lung Cancer Patients

Ann Rita Halvorsen, Laxmi Silwal‐Pandit, Leonardo A. Meza‐Zepeda et al. · Frontiers in Genetics · 2016 · 120 citations · Full text

, , +17

A comparison between p53 accumulation determined by immunohistochemistry and<i>TP53</i>mutations as prognostic variables in tumours from breast cancer patients

Jan Alsner, Vibeke Jensen, Marianne Kyndi et al. · Acta Oncologica · 2008 · 107 citations · Full text

, , +16

1–5 of 13